Identification of metastatic liver cancer

Fluorescent Imaging: Treatment of Hepatobiliary and Pancreatic Diseases

Volumn 31, Issue , 2013, Pages 18-24

  Lim, Chetana ^a   Vibert, Eric ^b,c  

^a HENRI MONDOR HOSPITAL   (France)

^b HÔPITAL PAUL BROUSSE   (France)

^c Kremlin Bicêtre Hospital   (France)

Author keywords

[No Author keywords available]

Indexed keywords

PATHOLOGY; TUMORS;

BILE DUCTS; INDOCYANINE GREEN; INTRA-OPERATIVE; LIVER METASTASIS; LIVER TUMORS; METASTATIC LIVER CANCERS; REAL TIME; SYSTEMATIC REVIEW;

FLUORESCENCE IMAGING;

EID: 84925736793     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1159/000350038     Document Type: Chapter

References (14)

1. Clavien PA, Petrowsky H, DeOliveira ML, Graf R: Strategies for safer liver surgery and partial liver transplantation. N Engl J Med 2007; 356: 1545-1559.
2. Adam R, Da Gramont A, Figueras J, et al: The oncosurgery approach to managing liver metastases from colorectal cancer: a multidisciplinary international consensus. Oncologist 2012; 17: 1225-1239.
3. Rees M, Tekkis PP, Welsh FK, O'Rourke T, John TG: Evaluation of long-term survival after hepatic resection for metastatic colorectal cancer: a multifactorial model of 929 patients. Ann Surg 2008; 247: 125-135.
4. Bolton JS, Fuhrman GM: Survival after resection of multiple bilobar hepatic metastases from colorectal carcinoma. Ann Surg 2000; 231: 743-751.
5. Adams RB, Aloia TA, Loyer E, et al: Selection for hepatic resection of colorectal liver metastases: expert consensus statement. HPB (Oxford) 2012; 15: 91-103.
6. Chami L, Lassau N, Malka D, et al: Benefits of contrast-enhanced sonography for the detection of liver lesions: comparison with histologic findings. AJR Am J Roentgenol 2008; 190: 683-690.
7. Leen E, Cecotti P, Moug SJ, et al: Potential value of contrast-enhanced intraoperative ultrasonography during partial hepatectomy for metastases: an essential investigation before resection? Ann Surg 2006; 243: 236-240.
8. Ishizawa T, Fukushima N, Shibahara J, et al: Realtime identification of liver cancers by using indocyanine green fluorescent imaging. Cancer 2009; 115: 2491-2504.
9. Benoist S, Brouquet A, Penna C, et al: Complete response of colorectal liver metastases after chemotherapy: does it mean cure? J Clin Oncol 2006; 24: 3939-3945.
10. Coffin CM, Diche T, Mahfouz A, et al: Benign and malignant hepatocellular tumors: evaluation of tumoral enhancement after mangafodipir trisodium injection on MR imaging. Eur Radiol 1999; 9: 444-449.
11. Chung JJ, Kim MJ, Kim KW: Mangafodipir trisodium-enhanced MRI for the detection and characterization of focal hepatic lesions: is delayed imaging useful? J Magn Reson Imaging 2006; 23: 706-711.
12. Uchiyama K, Ueno M, Ozawa S, et al: Combined use of contrast-enhanced intraoperative ultrasonography and a fluorescence navigation system for identifying hepatic metastases. World J Surg 2010; 34: 2953-2959.
13. Morita Y, Sakaguchi T, Unno N, et al: Detection of hepatocellular carcinomas with near-infrared fluorescence imaging using indocyanine green: its usefulness and limitation. Int J Clin Oncol 2011, E-pub ahead of print.
14. Cherrick GR, Stein SW, Leevy CM, Davidson CS: Indocyanine green: observations on its physical properties, plasma decay, and hepatic extraction. J Clin Invest 1960; 39: 592-600.